Redeye argues that the Q2 report was strong in all aspects. The continued strong AUM growth makes us raise our AUM estimates slightly. Also, we look deeper into Kaktus and we think some hidden value will be revealed next year. We raise our valuation.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/